Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Sensitivity and Acquired Resistance of BRCA1;p53-Deficient Mouse Mammary Tumors to the Topoisomerase I Inhibitor Topotecan

(2010) S. A.L. Zander et al.   CANCER RESEARCH

Ovarian Cancer

(2010) Young-Jeong Na et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

(2010) M William Audeh et al.   LANCET

Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas

(2009) Elizabeth M Swisher et al.   Molecular Cancer

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers

(2009) Peter C. Fong et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature

(2009) Digant Gupta et al.   Journal of Ovarian Research

The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer

(2008) Johanne Weberpals et al.   INTERNATIONAL JOURNAL OF CANCER